Regeneron Pharmaceuticals, Inc. logo REGN - Regeneron Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 32
HOLD 16
SELL 0
STRONG
SELL
0
| PRICE TARGET: $840.15 DETAILS
HIGH: $995.00
LOW: $641.00
MEDIAN: $857.50
CONSENSUS: $840.15
UPSIDE: 31.50%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Platform & Compounding FCF

AlphaQuality — archetype-weighted quantitative grade

B- 62.7 / 100 composite

Composite Grade

Composite of six pillars weighted for platform & compounding fcf businesses. Purely quantitative — no stock price or analyst input.

Profitability

Weight: 25%
C 54.9
  • 5yr Avg ROIC 14.5% 78/100
  • Operating Margin Trend -7.76 pp/yr 0/100
Contributes 13.7 pts toward composite.

Capital Efficiency

Weight: 15%
A- 80.9
  • 5yr Avg ROE 16.2% 83/100
  • 5yr Share-Count CAGR -0.8% 77/100
Contributes 12.1 pts toward composite.

Growth Quality

Weight: 25%
F 22.5
  • 5yr Revenue CAGR -2.8% 14/100
  • 5yr EPS CAGR -12.9% 0/100
  • Revenue-Growth Years (5) 4/5 80/100
Contributes 5.6 pts toward composite.

Cash Generation

Weight: 20%
A+ 95.4
  • 5yr FCF Margin 31.8% 100/100
  • 5yr FCF/NI Conversion 0.90x 90/100
Contributes 19.1 pts toward composite.

Balance Sheet

Weight: 10%
A+ 100.0
  • Net Debt / EBITDA -1.01x 100/100
  • Interest Coverage (EBIT/Int) 120.42x 100/100
  • Altman Z-Score 6.60 100/100
Contributes 10.0 pts toward composite.

Stability

Weight: 5%
C- 44.2
  • EPS Volatility (σ/μ) 0.67 17/100
  • Piotroski F-Score 5 56/100
  • Negative-Revenue Years (5) 1/5 80/100
Contributes 2.2 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 4 gurus held; 2 added; 2 trimmed.

Holders
4
Avg Δ position
+3931.7%
New buys
0
Full exits
0
As of Q1 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (25%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (25%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — EPS Volatility (σ/μ), Piotroski F-Score, Negative-Revenue Years (5)

We deliberately ignore stock price, analyst targets, and consensus ratings so the grade is suitable for backtesting forward returns. A minimum of 5 fiscal years of audited statements is required; distressed and highly leveraged infrastructure businesses are declared ungradable rather than forced into a numeric score.